Advos

Latest News

GeoVax to Provide Q1 2025 Financial Results and Strategic Update

GeoVax to Provide Q1 2025 Financial Results and Strategic Update

GeoVax Labs will host a conference call to discuss its first quarter 2025 financial performance and provide insights into its clinical development programs in COVID-19 vaccines and oncology therapies. The event offers investors and industry stakeholders an opportunity to gain comprehensive insights into the company's ongoing research and strategic direction.

Read the full story
Back To Top